Evidence map›Paper›PMID 37309259›Full record

ArticleJournal of neuroendocrinology2023

Constitutive and conditional deletion reveals distinct phenotypes driven by developmental versus neurotransmitter actions of the neuropeptide PACAP.

Dana Bakalar, Oksana Gavrilova, Sunny Z Jiang, Hai-Ying Zhang, Snehashis Roy, Sarah K Williams, Naili Liu, Stephen Wisser, Ted B Usdin, Lee E Eiden

Open access · greenAbstract read
In one paragraph

Article in Journal of neuroendocrinology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Nociceptors use multiple neurotransmitters to drive pain.bioRxiv : the preprint server for biology · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Advances in peptide modulation in systems physiology.Journal of neuroendocrinology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Dana BakalarSection on Molecular Neuroscience, National Institute of Mental Heath - Intramural Research Program, Bethesda, Maryland, USA.ORCID 0000-0001-8257-4427
Oksana GavrilovaMouse Metabolism Core Laboratory, National Institute of Diabetes and Kidney Disease- Intramural Research Program, Bethesda, Maryland, USA.
Sunny Z JiangSection on Molecular Neuroscience, National Institute of Mental Heath - Intramural Research Program, Bethesda, Maryland, USA.
Hai-Ying ZhangSection on Molecular Neuroscience, National Institute of Mental Heath - Intramural Research Program, Bethesda, Maryland, USA.
Snehashis RoySystems Neuroscience Imaging Resource, National Institute of Mental Heath - Intramural Research Program, Bethesda, Maryland, USA.
Sarah K WilliamsSystems Neuroscience Imaging Resource, National Institute of Mental Heath - Intramural Research Program, Bethesda, Maryland, USA.ORCID 0000-0002-9898-5420
Naili LiuMouse Metabolism Core Laboratory, National Institute of Diabetes and Kidney Disease- Intramural Research Program, Bethesda, Maryland, USA.
Stephen WisserSystems Neuroscience Imaging Resource, National Institute of Mental Heath - Intramural Research Program, Bethesda, Maryland, USA.
Ted B UsdinSystems Neuroscience Imaging Resource, National Institute of Mental Heath - Intramural Research Program, Bethesda, Maryland, USA.
Lee E EidenSection on Molecular Neuroscience, National Institute of Mental Heath - Intramural Research Program, Bethesda, Maryland, USA.ORCID 0000-0001-7524-944X
National Institute of Mental Health · USNational Institute of Diabetes and Digestive and Kidney Diseases · US

Funding

Chemical Coding Of NeurotransmissionZIAMH002386 · NIMH · NATIONAL INSTITUTE OF MENTAL HEALTH · PI EIDEN, LEE E. · 2009 to 2025
$25.6M
Systems Neuroscience Imaging ResourceZICMH002963 · NIMH · NATIONAL INSTITUTE OF MENTAL HEALTH · PI USDIN, THEODORE · 2017 to 2025
$18.0M
Metabolic Studies of Mouse Models of Obesity and DiabetesZICDK070002 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI GAVRILOVA, OKSANA · 2009 to 2025
$15.0M
Intramural NIH HHS ZIA MH002386
6 · The paper itself

Abstract

Neuropeptides may exert trophic effects during development, and then neurotransmitter roles in the developed nervous system. One way to associate peptide-deficiency phenotypes with either role is first to assess potential phenotypes in so-called constitutive knockout mice, and then proceed to specify, regionally and temporally, where and when neuropeptide expression is required to prevent these phenotypes. We have previously demonstrated that the well-known constellation of behavioral and metabolic phenotypes associated with constitutive pituitary adenylate cyclase-activating peptide (PACAP) knockout mice are accompanied by transcriptomic alterations of two types: those that distinguish the PACAP-null phenotype from wild-type (WT) in otherwise quiescent mice (cPRGs), and gene induction that occurs in response to acute environmental perturbation in WT mice that do not occur in knockout mice (aPRGs). Comparing constitutive PACAP knockout mice to a variety of temporally and regionally specific PACAP knockouts, we show that the prominent hyperlocomotor phenotype is a consequence of early loss of PACAP expression, is associated with Fos overexpression in hippocampus and basal ganglia, and that a thermoregulatory effect previously shown to be mediated by PACAP-expressing neurons of medial preoptic hypothalamus is independent of PACAP expression in those neurons in adult mice. In contrast, PACAP dependence of weight loss/hypophagia triggered by restraint stress, seen in constitutive PACAP knockout mice, is phenocopied in mice in which PACAP is deleted after neuronal differentiation. Our results imply that PACAP has a prominent role as a trophic factor early in development determining global central nervous system characteristics, and in addition a second, discrete set of functions as a neurotransmitter in the fully developed nervous system that support physiological and psychological responses to stress.

Indexed as

Neurotransmitter AgentsPituitary Adenylate Cyclase-Activating PolypeptideAnimalsMiceMice, KnockoutNeuronsPhenotypeNeurotransmitter AgentsPituitary Adenylate Cyclase-Activating Polypeptidedevelopmenthyperlocomotionneuropeptidespituitary adenylate cyclase-activating peptide (PACAP)thermoregulation

Identifiers

PMID37309259
PMCPMC10620107
OpenAlexW4367832250

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.